CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website. 

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Review CIRB
Study Status
Study Number Lead Group Study Title CIRB Study Status
S0227 SWOG Phase III Randomized Trial of Cisplatin/Paclitaxel Versus Cisplatin/Gemcitabine in Recurrent; Persistent; or Metastatic Carcinoma of the Cervix Adult CIRB - Late Phase Emphasis Completed
S0232 SWOG Double-Blinded Placebo Controlled Phase III Trial Comparing Dexamethasone (DEX) to the Combination of DEX + CC-5013 in Patients with Previously Untreated Multiple Myeloma who are Not Immediately Undergoing Autologous Stem Cell Transplant Adult CIRB - Late Phase Emphasis Completed
S0303 SWOG A Phase III Trial of Modified FOLFOX6 Versus CAPOX; with Bevacizumab (NSC-704865) or Placebo; as First-Line Therapy in Patients with Previously Untreated Advanced Colorectal Cancer Adult CIRB - Late Phase Emphasis Completed
S0307 SWOG Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer Adult CIRB - Late Phase Emphasis Completed
S0309 SWOG Myeloma Specimen Repository Protocol Ancillary Adult CIRB - Late Phase Emphasis Completed
S0334 SWOG Myeloma Specimen Repository Protocol Ancillary Adult CIRB - Late Phase Emphasis Completed
S0337 SWOG A Phase III Blinded Study of Immediate Post-TURBT Instillation of Gemcitabine Versus Saline in Patients with Newly Diagnosed or Occasionally Recurring Grade I/II Superficial Bladder Cancer Adult CIRB - Late Phase Emphasis Completed
S0347 SWOG A Randomized Study of Weekly Vinorelbine (Navelbine) Alone or in Combination with Trastuzumab (Herceptin) (NSC-688097) for Patients with HER-2-Positive Metastatic Breast Cancer Whose Tumors Have Progressed After Taxane + Trastuzumab Combination Therapy - Phase III Adult CIRB - Late Phase Emphasis Completed
S0421 SWOG Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients with Advanced Hormone Refractory Prostate Cancer Adult CIRB - Late Phase Emphasis Completed
S0427 SWOG A Phase III Trial of Standard Fractionation Radiation and Concurrent Single Agent Cisplatin; with and without Docetaxel; Cisplatin; and 5-FluorouracilInduction Chemotherapy; in Patients with Advanced Oropharyngeal Squamous Cell Cancer Adult CIRB - Late Phase Emphasis Completed